Moderna Inc (MRNA)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
Our last 30 days of resolved calls came true 29% of the time.See the track record →
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
- Weekly momentum+6.0% over the past week+6
- 12-month trend+502% over the past year+10
- 52-week positionAbove the midpoint of its 52-week range+9
- QualityRevenue shrinking (-28% y/y)-11
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →
🤖 The dominant catalyst here is **none** — the headlines are a mix of comparative analyst commentary, sector-wide mRNA sentiment, and adjacent healthcare news rather than a company-specific event like an earnings beat, product approval, or deal. Continuation likelihood is therefore low-to-moderate and largely headline-driven, with maybe a 30–40% probability that any near-term move persists over the next few weeks absent a fresh MRNA-specific catalyst. Informational only — not financial advice.
- Top S&P500 movers in Friday's sessionChartMill · 2026-09-11
- Stay informed with the top movers within the S&P500 index on Friday.ChartMill · 2026-09-11
- Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay FlatYahoo · 2026-09-11
- Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?Yahoo · 2026-09-11
- Frequency Electronics, ACV Auctions, HP And Other Big Stocks Moving Higher On FridayBenzinga · 2026-09-11
Any AI summary is an interpretation of public news, not advice or a price target.